Author:
Winston Alan,Boffito Marta
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference20 articles.
1. Palella FJ Jr, Deloria-Knoll M, Chmiel JS et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med2003; 138: 620–6.
2. Pozniak A, Gazzard B, Anderson J et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med2003; 4 (Suppl 1): 1–41.
3. Walmsley S, Bernstein B, King M et al. Lopinavir–ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med2002; 346: 2039–46.
4. Boffito M, Maitland D, Samarasinghe Y et al. The pharmacokinetics of HIV protease inhibitor combinations. Curr Opin Infect Dis2005; 18: 1–7.
5. Wire MB, Naderer OJ, Masterman AL et al. The pharmacokinetic (PK) interaction between GW433908 (908) with lopinavir (LPV)/ritonavir (RTV) (APV1011 and APV10012). In: Program and Abstracts of the Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2004. Abstract 612. National Institute of Allergy and Infectious Diseases and Centers for Disease Control and Prevention, USA.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献